| Name | Title | Contact Details |
|---|
Saint Francis Health Services is a Morris, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Premise Health is here to change the way people see and experience healthcare. We help organizations take healthcare farther – by bringing it closer than ever. We’ve created a worksite health model that achieves better patient engagement, and delivers higher-value programs that sustainably improve health outcomes to worksite and distributed workforces. For employers, this means finally controlling costs – while delivering a leading-edge health benefit that actually benefits health. On behalf of 220+ clients, Premise Health operates over 500 onsite health centers, pharmacies, and fitness centers in 46 states and 2 U.S. territories.
Global Marketing Resources Inc is a Dunedin, FL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Sponsored by the Franciscan Sisters of Mary and based in St. Louis, Mo., SSM Health Care (SSMHC) is one of the largest Catholic systems in the country.
BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.